Search Results - "Melo, Andreia"

SOLO 3 Trial: How Do the Results Fit in With Current Evidence? by Paulino, Eduardo, Melo, Andreia C

Get full text

Traditional medicines for COVID‐19: Perspectives from clinical pharmacologists by Yimer, Getnet, Ekuadzi, Edmund, Fasinu, Pius, Melo, Andreia Cristina, Pillai, Goonaseelan (Colin)

“…There has been high interest in the use of traditional medicines for COVID‐19 from early in the course of the pandemic. Significant advances in the science of…”
Get full text

Clinical Characteristics and Outcomes of a High-grade Endometrial Cancer Cohort Treated at Instituto Nacional de Câncer, Brazil by Paulino, Eduardo, Melo, Andreia Cristina de

“…Objective To analyze the outcomes of a cohort of patients with high-risk histologies of endometrial cancer (EC) treated at Instituto Nacional de Câncer…”
Get full text

Trends in the incidence and morbidity of Merkel cell carcinoma in Brazil by de Melo, Andreia C, Santos Thuler, Luiz C

“…The current study aims to present epidemiologic changes and clinical aspects of Merkel cell carcinoma (MCC) in Brazil. Data were collected from the Brazilian…”
Get full text

Exploring biomarkers and prognostic factors in uterine carcinosarcoma: An insight into L1CAM, CDX2, p53, and MSI status by da Silva, Jesse Lopes, de Albuquerque, Lucas Zanetti, Rodrigues, Fabiana Resende, Bastos, Nina Carrossini, Small, Isabele Avila, Barroso, Elisa Bouret Campos, Cordero, Fernando Lopes, Fernandes, Daniel de Souza, Paulino, Eduardo, de Melo, Andreia Cristina

“…Uterine Carcinosarcomas (UCS) are a rare type of cancer composed of an admixture of high-grade carcinomatous and sarcomatous elements. Clinicopathological…”
Get full text

Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer by Souza, Juliana L, Martins-Cardoso, Karina, Guimarães, Isabella S, de Melo, Andréia C, Lopes, Angela H, Monteiro, Robson Q, Almeida, Vitor H

“…Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase widely expressed in cervical tumors, being correlated with adverse clinical outcomes…”
Get full text

CDKN2A/CDK4 status in Brazilian patients meeting clinical criteria for hereditary melanoma: a cross‐sectional descriptive trial by Arnaut, Joyce R. M. B., Guimarães, Isabella dos S., Santos, Anna Cláudia E., Rodrigues, Elizângela M., Machado, Jorge R. da S., Melo, Andreia C.

“…Background Melanoma is the most lethal skin cancer, and its incidence has increased worldwide. About 10% of cases are classified as hereditary melanoma (HM)…”
Get full text

Importance of pain score distribution to interpretation of the minimal clinically important difference by Araujo, Bruno L de C, de Melo, Andreia C, Santos Thuler, Luiz C

Get more information

EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer by Oaknin, Ana, Monk, Bradley J., Vergote, Ignace, Cristina de Melo, Andreia, Kim, Yong-Man, Lisyanskaya, Alla S., Samouëlian, Vanessa, Kim, Hee Seung, Gotovkin, Evgeniy A., Damian, Fernanda, Chang, Chih-Long, Takahashi, Shunji, Li, Jingjin, Mathias, Melissa, Fury, Matthew G., Ivanescu, Cristina, Reaney, Matthew, LaFontaine, Patrick R., Lowy, Israel, Harnett, James, Chen, Chieh-I, Tewari, Krishnansu S.

“…Background: In a phase III, randomised, active-controlled study (EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9; R2810-ONC-1676; NCT03257267) and cemiplimab…”
Get full text

Advanced Cervical Cancer: Leveraging the Historical Threshold of Overall Survival by Paulino, Eduardo, Melo, Andreia Cristina de

Get full text

First‐line atezolizumab monotherapy in patients with advanced BRAFV600 wild‐type melanoma by Azevedo, Sergio Jobim, Melo, Andreia Cristina, Roberts, Louise, Caro, Ivor, Xue, Cloris, Wainstein, Alberto

“…Anti‐programmed death‐1 agents are an established option for advanced melanoma, but the anti‐programmed death‐ligand 1 (anti‐PD‐L1) antibody atezolizumab, an…”
Get full text

Epidemiology of tongue squamous cell carcinoma: A retrospective cohort study by Silva Souto, Ana Carolina, Vieira Heimlich, Fernanda, Lima de Oliveira, Leticia, Bergmann, Anke, Dias, Fernando Luiz, Spíndola Antunes, Héliton, Melo, Andreia Cristina, Thuler, Luiz Claudio Santos, Cohen Goldemberg, Daniel

“…Objective To analyze the epidemiological profile and the specific survival of patients diagnosed with tongue squamous cell carcinoma at the National Cancer…”
Get full text

Epidemiology of major salivary gland cancer in Brazil: Incidence, morbidity, and mortality by Cohen Goldemberg, Daniel, Alves, Lísia Daltro Borges, Antunes, Héliton Spindola, Thuler, Luiz Claudio Santos, Melo, Andreia Cristina

Get full text

Implementation of a pharmacogenomic program in a Brazilian public institution by Suarez-Kurtz, Guilherme, Kovaleski, Giovana, Elias, Anna Br, Motta, Vera LA, Wolch, Karolyne, Emerenciano, Mariana, Mansur, Marcela B, Palladino, Alexandre M, Accioly, Maria T, Ferreira, Marcos, Gonçalves, Antonio A, de Melo, Andréia C

“…This narrative review describes implementation, current status and perspectives of a pharmacogenomic (PGx) program at the Brazilian National Cancer Institute…”
Get full text

Merkel cell carcinoma: epidemiology, clinical features, diagnosis and treatment of a rare disease by Siqueira, Stella Oliveira Meireles, Campos-do-Carmo, Gabriella, dos Santos, Alexssandra Lima Siqueira, Martins, Cícero, de Melo, Andreia Cristina

“…Merkel cell carcinoma is a rare skin cancer with neuroendocrine differentiation. The risk factors include sun exposure, advanced age, immunosuppression (such…”
Get full text

Epidemiological profile of mucosal melanoma in Brazil by Cohen Goldemberg, Daniel, de Melo, Andreia Cristina, de Melo Pino, Livia Cristina, Thuler, Luiz Claudio Santos

“…Mucosal melanomas are primary malignant neoplasias originated from melanocytes within mucous membranes in any part of mucosal surface lining, more commonly, in…”
Get full text

Factors influencing COVID-19 mortality among cancer patients: A Brazilian multi-institutional study by da Silva, Jessé Lopes, de Souza, Bruno Santos Wance, de Albuquerque, Lucas Zanetti, Aleixo, Sabina Bandeira, Resende, Gilmara Anne da Silva, de Oliveira, Daniela Galvão Barros, Dos Santos, Emerson Neves, Nogueira-Rodrigues, Angélica, Clara, Renan Orsati, Gaui, Maria de Fatima Dias, Mota, Augusto Cesar de Andrade, de Lima, Vladmir Claudio Cordeiro, Rosa, Daniela Dornelles, Munhoz, Rodrigo Ramella, Morbeck, Igor Alexandre Protzner, Gelatti, Ana Caroline Zimmer, Mathias, Clarissa Maria de Cerqueira, de Melo, Andréia Cristina

“…This study aimed to describe the demographic and clinical characteristics of cancer patients with COVID-19, exploring factors associated with adverse outcomes…”
Get full text

Induction Chemotherapy and Chemoradiotherapy Combined to ASA vs. Placebo for High-Risk Rectal Cancer: Results of a Randomized Trial by Ominelli, Juliana, Araujo, Rodrigo O. de Castro, Valadão, Marcus, Padoan, Monica L.A., Lopes dos Santos, Victor M., Dutra, Jamille G., Torres, Claudia C., Barbosa, Monique A., Guimarães, Raquel, Carvalho, Juliana C. Carneiro, Ferreira, Maria A., de Oliveira, Ivanir M., Small, Isabele, de Melo, Andréia C., Araujo, Luiz H.

“…chemotherapy (IC) followed by chemoradiation (CRT) is an attractive approach in high-risk locally advanced rectal cancer. Additionally, ASA has shown potential…”
Get full text

Serological evidence of Ehrlichia minasensis infection in Brazilian dogs by Melo, Andréia Lima Tomé, Luo, Tian, Zhang, Xiaofeng, Muraro, Lívia Saab, Pereira, Nathalia Assis, Cabezas-Cruz, Alejandro, Dantas-Torres, Filipe, McBride, Jere W., de Aguiar, Daniel Moura

“…•Multiple ehrlichial agents can infect dogs in Brazil.•This is the first serological evidence of E. minasensis infection in dogs in Brazil.•Two isolates of E…”
Get full text

The Evolving Field of Neoadjuvant Therapy in Locally-advanced Rectal Cancer: Evidence and Prospects by Ominelli, Juliana, Valadão, Marcus, Araujo, Rodrigo Otavio de Castro, Cristina de Melo, Andréia, Araujo, Luiz H.

“…The standard treatment of locally advanced rectal cancer comprises neoadjuvant chemoradiation followed by total mesorectal excision. This strategy provides low…”
Get full text